Kazuhiro Umeda
Directeur Général chez M3i, Inc.
Profil
Kazuhiro Umeda is currently the Chief Executive Officer at M3i, Inc., Director at POC Clinical Research, Inc., and Director at PorMedTec Co., Ltd.
He previously worked as a Director at A-CUBE, Inc., Manager at Japan Asia Investment Co. Ltd.
(Private Equity), Investment & Business Development Manager at JAIC America, Inc., and Independent Outside Director at StemRIM, Inc. Mr. Umeda received his undergraduate and graduate degrees from the University of Tokyo.
Postes actifs de Kazuhiro Umeda
Sociétés | Poste | Début |
---|---|---|
M3i, Inc. | Directeur Général | 22/03/2016 |
POC Clinical Research, Inc. | Directeur/Membre du Conseil | 01/10/2015 |
PorMedTec Co., Ltd.
PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Directeur/Membre du Conseil | 01/12/2017 |
Anciens postes connus de Kazuhiro Umeda
Sociétés | Poste | Fin |
---|---|---|
STEMRIM | Directeur/Membre du Conseil | 29/10/2020 |
JAIC America, Inc.
JAIC America, Inc. Investment ManagersFinance JAIC America, Inc. (JAIC America) is a venture capital subsidiary of Japan Asia Investment Co., Ltd. founded in 1999. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 30/10/2010 |
Japan Asia Investment Co. Ltd. (Private Equity)
Japan Asia Investment Co. Ltd. (Private Equity) Investment ManagersFinance Japan Asia Investment Co. Ltd (JAIC) is a private equity subsidary of Japan Asia Investment Co Ltd. founded in 1981. The firm is headquartered in Tokyo, Japan. | Corporate Officer/Principal | 31/12/2007 |
A-CUBE, Inc.
A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Directeur/Membre du Conseil | - |
Formation de Kazuhiro Umeda
University of Tokyo | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
STEMRIM | Commercial Services |
Entreprise privées | 6 |
---|---|
M3i, Inc. | Finance |
POC Clinical Research, Inc. | |
PorMedTec Co., Ltd.
PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Health Technology |
Japan Asia Investment Co. Ltd. (Private Equity)
Japan Asia Investment Co. Ltd. (Private Equity) Investment ManagersFinance Japan Asia Investment Co. Ltd (JAIC) is a private equity subsidary of Japan Asia Investment Co Ltd. founded in 1981. The firm is headquartered in Tokyo, Japan. | Finance |
JAIC America, Inc.
JAIC America, Inc. Investment ManagersFinance JAIC America, Inc. (JAIC America) is a venture capital subsidiary of Japan Asia Investment Co., Ltd. founded in 1999. The firm is headquartered in Palo Alto, California. | Finance |
A-CUBE, Inc.
A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Health Technology |